Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humatrope in Pediatric Patients With SHOX Deficiency
NCT00190658Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2000
- Primary completion
- Jul 2004
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of somatropin in Short Stature Homeobox-Containing Gene Deficiency (3 arms), sponsored by Eli Lilly and Company. Primary endpoint: First year height velocity at 1 year. Started Feb 2000; status: completed.
02
Drugs
somatropin
03
Conditions
Short Stature Homeobox-Containing Gene Deficiency
Beyond the preview
Go deeper on NCT00190658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190658.